Back to Peptides
Hormone FDA Approved

Vosoritide

An FDA-approved C-type natriuretic peptide analog marketed as Voxzogo for achondroplasia.

CNP AnalogFDA ApprovedAchondroplasiaRare Disease

Also referenced as: Voxzogo

Status
FDA Approved

This peptide maps to at least one regulated medical product or label context in the United States.

Category
Hormone

This profile is grouped by its dominant research and market lane, not by vendor shelf placement.

Aliases
1

Voxzogo

Signal depth
High

FDA label signal · 18 trials · 100 PubMed results

What vosoritide is

Vosoritide is a C-type natriuretic peptide analog marketed as Voxzogo.

Why it matters

It brings another important approved peptide therapy into the library and broadens the site beyond the same few internet-famous compound classes.

Regulatory context

Vosoritide is FDA approved in the United States.

Practical reading note

Vosoritide is a good reminder that approved peptide therapeutics span far beyond weight loss, anti-aging, or performance claims.